Sperm donors offered by CryoGam are selected according to a variety of strict criteria. Nearly 98% of donors who apply for the program are denied. Our rigorous selection process provides our patients with excellent donor sperm. The selection process includes:
  • Three generation medical and genetic history
  • Personal interview
  • Genetic review analysis of donor's health history
  • Physical examination
  • Laboratory screening and testing
Once a donor has been selected for the program, all frozen sperm samples are subject to a 180-day or more quarantine period prior to release. The donor must pass repeat screening and testing before CryoGam will release the samples for sale. This screening process helps to ensure sperm quality and to minimize the potential for transmitting infectious agents.

Donors complete the following testing prior to release of their sperm specimens:

Initial Testing:
  • Complete semen analysis
  • Blood Type and RH
  • ALT
  • HIV-1 and HIV-2
  • HIV-1 (NAT)
  • HTLV-I and HTLV-II
  • Syphilis
  • Nisseria gonorrhea
  • Chlamydia tracomatis
  • Cytomegalovirus (CMV) Total (reflexive IgG and IgM if necessary) - click here for CMV info
  • Hepatitis B core antibody
  • Hepatitis B surface antigen
  • Hepatitis C antibody
  • Hepatitis C (NAT)
Repeat Testing Every Six-Months:
  • HIV-1 and HIV-2
  • HIV-1 (NAT)
  • HTLV-I and HTLV-II
  • Syphilis
  • Nisseria gonorrhea
  • Chlamydia tracomatis
  • Cytomegalovirus (CMV) Total (reflexive IgG and IgM if necessary) - click here for CMV info
  • Hepatitis B core antibody
  • Hepatitis B surface antigen
  • Hepatitis C antibody
  • Hepatitis C (NAT)

Genetic Testing:
  • Thalassemia, Tay Sachs, Sickle Cell, and Karyotype testing on donors whose ethnic origin put them at a higher risk for these genetic disease.

  • Starting January 2012, donors currently active in the program will be screened for Cystic Fibrosis.
NEW in 2012.....
CryoGam will begin screening all new donors for Cystic Fibrosis.

CryoGam has always completed Thalassemia, Tay Sachs, Sickle Cell, and Karyotype testing on donors whose ethnic origin put them at a higher risk for these genetic disease; however, we will begin to screen all new donors for Cystic Fibrosis. Some donors already have Cystic Fibrosis testing completed and more donors should be available soon. Please see our Donor List for available donors with Cystic Fibrosis testing.